ARTICLE | Company News
BTG, Nordion deal
July 22, 2013 7:00 AM UTC
BTG completed its acquisition of Therasphere liver cancer therapy from Nordion for $200 million. The yttrium-90 glass microspheres used for localized radioembolization therapy is approved in Europe a...